Back to All States

Boehringer Ingelheim Corporation | Company Profile, Marketing Contacts, Media Spend, Brands




Headquartered in Ridgefield, CT, Boehringer Ingelheim Corporation is a family-owned pharamceutical company that consists of a group of companies dedicated to the research, development and marketing of human and animal pharmaceuticals. A subsidiary of C.H. Boehringer Sohn, the medical segments regarding human health include prescriptions, consumer health and biopharmaceuticals.

Main Telephone
(203) 798-9988
Primary Address
900 Ridgebury Road
AOB Building
Ridgefield, CT 06877
USA

Boehringer Ingelheim Corporation Marketing Contacts

Contacts (5/91)
Name Title State
Greg G. Zone Director, Biosimilar Sales - West CT
Sample of Related Brands
***********
Email: *****@*******.***
Main Phone: (203) 798-9988
Direct Phone: *** **** ***   ext: ****
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: 900 Ridgebury Road
AOB Building
Ridgefield, CT
06877
USA

Erin A. Chief, Staff & Director, Human Resources Strategy & Operations CT
Michael S. Senior Associate Director, Specialty Marketing - Dermatology CT
Brian O. Director, Pipeline Marketing - Oncology CT
Susan H. Director, Human Pharma Communications & Corporate Affairs CT

Boehringer Ingelheim Corporation Ad Spend

Media Spend Summary
Media Spend Channel

Boehringer Ingelheim Corporation Related Brands

Brand Media Spend
Aggrenox *
Atrovent *
Catapres *
Mirapex *
Viramune *

Boehringer Ingelheim Corporation Agency Roster


Brand Agency Service From To
********** ********* *********** ********* Creative, Digital, Media Buying, Media Planning, Social, Public Relations
********** ********* *********** ****** *** **** Creative
********* ****** *** **** Creative

See Winmo sales intelligence in action

WinmoEdge Articles on Boehringer Ingelheim Corporation

Boehringer Ingelheim buys Zantac marketing rights


The Story Pharmaceutical company Boehringer Ingelheim will buy the U.S. marketing rights for heartburn medication Zantac, according to BusinessWeek.   Boehringer purchased the over-the-counter ...